Dermatology News

Guselkumab is comparable to interleukin-17A and subcutaneous TNF inhibitors for efficacy, and demonstrated a better PASI response relative to other drugs, in patients with psoriatic arthritis, according to a meta-analysis published in Rheumatology.

The shift to video conferencing during the COVID-19 pandemic has had a negative effect on self-perceptions, according to a study presented at AAD VMX 2021.

Cutaneous reactions to the mRNA-based COVID-19 vaccines were mostly minor and self-limited and should not discourage individuals from receiving a vaccine, according to a study.

Janus kinase inhibitors “may prove useful” in a wider range of immune-mediated inflammatory diseases, including refractory cutaneous dermatomyositis, chronic plaque psoriasis and other conditions, according to a speaker here.

Acne vulgaris (acne) is a common dermatologic condition affecting most adolescents and young adults. It is a complex condition that involves multiple factors.

Experimental studies indicate that sleep loss can lead to elevated concentrations of proinflammatory cytokines and enhance the perception of pain among patients with immune-mediated inflammatory diseases, according to a speaker here.

The combined “derm-rheum” clinic offers a unique opportunity to streamline care and improve drug access for patients with psoriatic arthritis while enhancing cross-disciplinary education among dermatologists and rheumatologists, noted a speaker at a recent summit.

A 17-year-old male comes to your ED with increasing, generalized pruritus and the development of diffuse erythema.

Clinicians should consider the heterogeneity of psoriatic arthritis when selecting therapeutic options, according to a speaker at the ACR State-of-the-Art Clinical Symposium.

Although the overall incidence of psoriatic arthritis in the United States remained stable from 2000 to 2017, there was a 3% per-year increase among women during this time, according to data published in Arthritis & Rheumatology.